Get startedLog in
    Picture of IGC Pharma logo

    IGC — IGC Pharma News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMicro CapMomentum Trap
    All News

    Brief: IGC Completes Cohort 2 Of Its Phase 1 THC-Based Clinical Trial On Alzheimer's Patients

    Picture of IGC Pharma logoIGC Pharma
    08/06/2021 04:28
    June 7 (Reuters) - India Globalization Capital Inc  IGC.A :
    * IGC COMPLETES COHORT 2 OF ITS PHASE 1 THC-BASED CLINICAL
TRIAL
ON ALZHEIMER’S PATIENTS
    * INDIA GLOBALIZATION CAPITAL - PHASE 1 CLINICAL TRIAL ON
ALZHEIMER'S PATIENTS IS ANTICIPATED TO CONCLUDE DURING JULY
THROUGH SEPTEMBER 2021 TIMEFRAME

Source text for Eikon:  ID:nBw3GFjRSa 
Further company coverage:  IGC.A 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on IGC Pharma

    See all news